The impact of utilizing donation after circulatory death (DCD) hearts on waitlist outcomes has not been substantiated. We retrospectively analyzed 184 heart transplant (HT) candidates at our institution from 2019 to 2021. Patients were stratified into two observation periods centered on September 12, 2020, when the adult DCD HT program officially began. Primary outcome was a comparison of transplant rate between Period 1 (pre-DCD) and Period 2 (post-DCD). Secondary outcomes included waitlist time-to-transplant, waitlist mortality rate, independent predictors of incidence of HT, and post-transplant outcomes. A total of 165 HTs (n=92 in Period 1 and n=73 in Period 2) were performed. Median waitlist time-to-transplant decreased from 47.5 to 19 days in Period 1 and Period 2, respectively (p=0.004). Transplant rate increased from 181 per 100 patient-years in Period 1 to 579 per 100 patient-years in Period 2 (IRR 1.87, 95% CI 1.04-3.38, p=0.038). There were no statistical differences in waitlist mortality rate (p=0.566) and 1-year survival (p=0.699) between the two periods. DCD HTs (n=36) contributed to 49.3% of overall HT activity in Period 2. We concluded that utilization of DCD hearts significantly reduced waitlist time and increased transplant rate. Short-term post-transplant outcomes were comparable between the pre- and post-DCD periods.